Breaking News

Session at AAPS National Biotechnology Conference to Cover Gene & Therapy Market

‘Cell and Gene Therapies at the Intersection of Business and Science,’ will take place on May 14 at 9:30 a.m. in San Francisco.

Author Image

By: Charlie Sternberg

Associate Editor

The exclusive executive track session, “Cell and Gene Therapies at the Intersection of Business and Science,” will take place on May 14 at 9:30 a.m. during the AAPS National Biotechnology Conference (NBC) in San Francisco.   Potens Pharmaceuticals Founder Praveen Tyle, Ph.D., will moderate a panel focused on the current state of cell and gene therapies. The discussion will center on practical insights into how biotech leaders are addressing market pain points, e.g., global market access, devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters